Artykuły w czasopismach na temat „Cxcr1-2”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cxcr1-2”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Zhang, Jing, Shouguo Huang, Lini Quan, Qiu Meng, Haiyan Wang, Jie Wang i Jin Chen. "Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis". BioMed Research International 2021 (19.03.2021): 1–13. http://dx.doi.org/10.1155/2021/8883800.
Pełny tekst źródłaDoroshenko, Tatyana, Yuri Chaly, Valery Savitskiy, Olga Maslakova, Anna Portyanko, Irina Gorudko i Nikolai N. Voitenok. "Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2". Blood 100, nr 7 (1.10.2002): 2668–71. http://dx.doi.org/10.1182/blood.100.7.2668.
Pełny tekst źródłaKonrad, F. M., i J. Reutershan. "CXCR2 in Acute Lung Injury". Mediators of Inflammation 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/740987.
Pełny tekst źródłaFeniger-Barish, Rotem, Dan Belkin, Alon Zaslaver, Shira Gal, Mally Dori, Maya Ran i Adit Ben-Baruch. "GCP-2–induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR+-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling". Blood 95, nr 5 (1.03.2000): 1551–59. http://dx.doi.org/10.1182/blood.v95.5.1551.005a36_1551_1559.
Pełny tekst źródłaSmithson, Alex, Maria Rosa Sarrias, Juanjo Barcelo, Belen Suarez, Juan Pablo Horcajada, Sara Maria Soto, Alex Soriano i in. "Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections". Clinical Diagnostic Laboratory Immunology 12, nr 12 (grudzień 2005): 1358–63. http://dx.doi.org/10.1128/cdli.12.12.1358-1363.2005.
Pełny tekst źródłaMolczyk, Caitlin, i Rakesh K. Singh. "CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors". Biomedicines 11, nr 2 (16.02.2023): 576. http://dx.doi.org/10.3390/biomedicines11020576.
Pełny tekst źródłaNgo, Hai, Evdoxia Hatjiharissi, Xavier Leleu, Judith Runnels, Anne-Sophie Moreau, Xiaoying Jia, Garrett O’Sullivan i in. "The CXCR4/SDF-1 Axis Regulates Migration and Adhesion in Waldenstrom Macroglobulinemia." Blood 108, nr 11 (1.11.2006): 2418. http://dx.doi.org/10.1182/blood.v108.11.2418.2418.
Pełny tekst źródłaKhandaker, Masud H., Luoling Xu, Rahbar Rahimpour, Gordon Mitchell, Mark E. DeVries, J. Geoffrey Pickering, Sharwan K. Singhal, Ross D. Feldman i David J. Kelvin. "CXCR1 and CXCR2 Are Rapidly Down-Modulated by Bacterial Endotoxin Through a Unique Agonist-Independent, Tyrosine Kinase-Dependent Mechanism". Journal of Immunology 161, nr 4 (15.08.1998): 1930–38. http://dx.doi.org/10.4049/jimmunol.161.4.1930.
Pełny tekst źródłaVacchini, Alessandro, Anneleen Mortier, Paul Proost, Massimo Locati, Mieke Metzemaekers i Elena Borroni. "Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties". International Journal of Molecular Sciences 19, nr 12 (27.11.2018): 3768. http://dx.doi.org/10.3390/ijms19123768.
Pełny tekst źródłaBurton, Victoria J., Alan M. Holmes, Loredana I. Ciuclan, Alexander Robinson, Jan S. Roger, Gabor Jarai, Andrew C. Pearce i David C. Budd. "Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II". Blood 118, nr 17 (27.10.2011): 4750–58. http://dx.doi.org/10.1182/blood-2011-05-347393.
Pełny tekst źródłaBrowning, Darren D., Wade C. Diehl, Matthew H. Hsu, Ingrid U. Schraufstatter i Richard D. Ye. "Autocrine regulation of interleukin-8 production in human monocytes". American Journal of Physiology-Lung Cellular and Molecular Physiology 279, nr 6 (1.12.2000): L1129—L1136. http://dx.doi.org/10.1152/ajplung.2000.279.6.l1129.
Pełny tekst źródłaInngjerdingen, Marit, Bassam Damaj i Azzam A. Maghazachi. "Expression and regulation of chemokine receptors in human natural killer cells". Blood 97, nr 2 (15.01.2001): 367–75. http://dx.doi.org/10.1182/blood.v97.2.367.
Pełny tekst źródłade Jong, Madelon M. E., Cathelijne Fokkema, Natalie Papazian, Sabrin Tahri, Zoltan Kellermayer, Michael Vermeulen, Mark van Duin i in. "Inflammasome-Primed Myeloid Cells Maintain a Pro-Tumor Microenvironment in Multiple Myeloma". Blood 138, Supplement 1 (5.11.2021): 2679. http://dx.doi.org/10.1182/blood-2021-150327.
Pełny tekst źródłaTroppan, Katharina, Kerstin Wenzl, Peter Neumeister, Christine Beham-Schmid, Martina Przekopowitz, Hildegard T. Greinix, Helmut Schaider i Alexander JA Deutsch. "The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome". Blood 126, nr 23 (3.12.2015): 3890. http://dx.doi.org/10.1182/blood.v126.23.3890.3890.
Pełny tekst źródłaTeijeira, Alvaro, Saray Garasa, Itziar Migueliz, Assunta Cirella i Ignacio Melero. "755 CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (listopad 2020): A803. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0755.
Pełny tekst źródłaBie, Yaqin, Wei Ge, Zhibin Yang, Xianshuo Cheng, Zefeng Zhao, Shengjie Li, Wenchao Wang i in. "The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis". Disease Markers 2019 (20.11.2019): 1–12. http://dx.doi.org/10.1155/2019/8023460.
Pełny tekst źródłaUllman, Nicholas A., Luis I. Ruffolo, Katherine M. Jackson, Alexander Chacon, Mary Georger, Rachel Jewell, Brian A. Belt, Dean Maeda, John Zebala i David Linehan. "CXCR1/2 blockade to enhance response to immune checkpoint inhibition in an aggressive orthotopic pancreatic adenocarcinoma model." Journal of Clinical Oncology 38, nr 5_suppl (10.02.2020): 19. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.19.
Pełny tekst źródłaMolczyk, Caitlin, Elizabeth Thomas, Lubaba Zaman, Paran Goel i Rakesh K. Singh. "Abstract 894: CXCR1: A novel therapeutic avenue for CSC-like phenotypes in pancreatic ductal adenocarcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 894. http://dx.doi.org/10.1158/1538-7445.am2022-894.
Pełny tekst źródłaStadlbauer, V., R. P. Mookerjee, G. A. K. Wright, N. A. Davies, G. Jürgens, S. Hallström i R. Jalan. "Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis". American Journal of Physiology-Gastrointestinal and Liver Physiology 296, nr 1 (styczeń 2009): G15—G22. http://dx.doi.org/10.1152/ajpgi.90512.2008.
Pełny tekst źródłaTakata, Hiroshi, Takuya Naruto i Masafumi Takiguchi. "Functional heterogeneity of human effector CD8+ T cells". Blood 119, nr 6 (9.02.2012): 1390–98. http://dx.doi.org/10.1182/blood-2011-03-343251.
Pełny tekst źródłaМурашко, Д. И., А. Д. Таганович i Н. Н. Ковганко. "Combined Determination of CXCR1, CXCR2, Hyaluronic Acid and CYFRA 21-1 Receptors in the Blood in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал, nr 3 (1.11.2022): 201–16. http://dx.doi.org/10.34883/pi.2022.10.3.014.
Pełny tekst źródłaPetering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp i Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, nr 2 (15.01.1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.
Pełny tekst źródłaPetering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp i Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, nr 2 (15.01.1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.402k31_694_702.
Pełny tekst źródłaLe Naour, Augustin, Mélissa Prat, Benoît Thibault, Renaud Mével, Léa Lemaitre, Hélène Leray, Marie-Véronique Joubert i in. "Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors". Journal of Molecular Cell Biology 12, nr 3 (3.09.2019): 202–15. http://dx.doi.org/10.1093/jmcb/mjz090.
Pełny tekst źródłaТаганович, А. Д., Н. Н. Ковганко, Г. Л. Гуревич, Г. К. Новская, О. А. Будник, О. В. Готько i В. И. Прохорова. "Verification of Blood Inflammatory Biomarkers Changes in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал 12, nr 1 (25.03.2024): 64–72. http://dx.doi.org/10.34883/pi.2024.12.1.024.
Pełny tekst źródłaCho, Hee Seong, Young In Choi, Seon Uk Park, Yi Seul Han, Jean Kwon i Sung Jun Jung. "Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2". International Journal of Molecular Sciences 24, nr 3 (17.01.2023): 1855. http://dx.doi.org/10.3390/ijms24031855.
Pełny tekst źródłaXing, Dongqi, J. Michael Wells, Samantha S. Giordano, Wenguang Feng, Amit Gaggar, Jie Yan, Fadi G. Hage, Li Li, Yiu-Fai Chen i Suzanne Oparil. "Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury". Journal of Applied Physiology 127, nr 2 (1.08.2019): 444–56. http://dx.doi.org/10.1152/japplphysiol.00587.2018.
Pełny tekst źródłaWolf, Marlene, Maria Belen Delgado, Simon A. Jones, Beatrice Dewald, Ian Clark-Lewis i Marco Baggiolini. "Granulocyte chemotactic protein 2 acts via both IL- 8 receptors, CXCR1 and CXCR2". European Journal of Immunology 28, nr 1 (styczeń 1998): 164–70. http://dx.doi.org/10.1002/(sici)1521-4141(199801)28:01<164::aid-immu164>3.0.co;2-s.
Pełny tekst źródłaLiu, Qian, Anping Li, Yijun Tian, Jennifer D. Wu, Yu Liu, Tengfei Li, Yuan Chen, Xinwei Han i Kongming Wu. "The CXCL8-CXCR1/2 pathways in cancer". Cytokine & Growth Factor Reviews 31 (październik 2016): 61–71. http://dx.doi.org/10.1016/j.cytogfr.2016.08.002.
Pełny tekst źródłaBlaser, Bradley Wayne, Jessica Moore, Brian LI, Owen J. Tamplin, Vera Binder i Leonard I. Zon. "IL-8 and CXCR1 Remodel the Vascular Niche to Promote Hematopoietic Stem and Progenitor Cell Engraftment". Blood 126, nr 23 (3.12.2015): 783. http://dx.doi.org/10.1182/blood.v126.23.783.783.
Pełny tekst źródłaPenco-Campillo, Manon, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco i in. "Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas". Cells 11, nr 23 (5.12.2022): 3933. http://dx.doi.org/10.3390/cells11233933.
Pełny tekst źródłaLee, Kyung-Soon, Edelmar Navaluna, Nicole M. Marsh, Eric M. Janezic i Chris Hague. "Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells". SLAS DISCOVERY: Advancing the Science of Drug Discovery 26, nr 4 (5.01.2021): 570–78. http://dx.doi.org/10.1177/2472555220979793.
Pełny tekst źródłaLaura, Brandolini, Benedetti Elisabetta, Ruffini Pier Adelchi, Russo Roberto, Cristiano Loredana, Antonosante Andrea, d’Angelo Michele i in. "CXCR1/2 pathways in paclitaxel-induced neuropathic pain". Oncotarget 8, nr 14 (20.02.2017): 23188–201. http://dx.doi.org/10.18632/oncotarget.15533.
Pełny tekst źródłaPawlick, Rena L., John Wink, Andrew R. Pepper, Antonio Bruni, Nasser Abualhassen, Yasmin Rafiei, Boris Gala-Lopez, Mariusz Bral i A. M. James Shapiro. "Reparixin, a CXCR1/2 inhibitor in islet allotransplantation". Islets 8, nr 5 (21.06.2016): 115–24. http://dx.doi.org/10.1080/19382014.2016.1199303.
Pełny tekst źródłaLima, Leonardo R. de, Heloisa M. F. Mendes, Frederico M. Soriani, Danielle G. de Souza, Geraldo Eleno S. Alves, Mauro M. Teixeira i Rafael R. Faleiros. "Histologic and inflammatory lamellar changes in horses with oligofructose-induced laminitis treated with a CXCR1/2 antagonist". Pesquisa Veterinária Brasileira 36, nr 1 (styczeń 2016): 13–18. http://dx.doi.org/10.1590/s0100-736x2016000100002.
Pełny tekst źródłaHenrot, Pauline, Renaud Prevel, Patrick Berger i Isabelle Dupin. "Chemokines in COPD: From Implication to Therapeutic Use". International Journal of Molecular Sciences 20, nr 11 (6.06.2019): 2785. http://dx.doi.org/10.3390/ijms20112785.
Pełny tekst źródłaGhasemzadeh, Mehran, Zane S. Kaplan, Imala Alwis, Simone M. Schoenwaelder, Katrina J. Ashworth, Erik Westein, Ehteramolsadat Hosseini i in. "The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi". Blood 121, nr 22 (30.05.2013): 4555–66. http://dx.doi.org/10.1182/blood-2012-09-459636.
Pełny tekst źródłaWong, Yin Ping, Noorhafizah Wagiman, Jonathan Wei De Tan, Barizah Syahirah Hanim, Muhammad Syamil Hilman Rashidan, Kai Mun Fong, Naufal Naqib Norhazli i in. "Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes". Diagnostics 12, nr 4 (1.04.2022): 882. http://dx.doi.org/10.3390/diagnostics12040882.
Pełny tekst źródłaMekhloufi, Abdelilah, Andrea Kosta, Helena Stabile, Rosa Molfetta, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli i in. "Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor". Cancers 12, nr 2 (13.02.2020): 440. http://dx.doi.org/10.3390/cancers12020440.
Pełny tekst źródłaLippert, Undine, Metin Artuc, Andreas Grützkau, Annelie Möller, Anna Kenderessy-Szabo, Dirk Schadendorf, Johannes Norgauer i in. "Expression and Functional Activity of the IL-8 Receptor Type CXCR1 and CXCR2 on Human Mast Cells". Journal of Immunology 161, nr 5 (1.09.1998): 2600–2608. http://dx.doi.org/10.4049/jimmunol.161.5.2600.
Pełny tekst źródłaCastelli, Vanessa, Laura Brandolini, Michele d’Angelo, Cristina Giorgio, Margherita Alfonsetti, Pasquale Cocchiaro, Francesca Lombardi, Annamaria Cimini i Marcello Allegretti. "CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling". Cells 10, nr 9 (6.09.2021): 2324. http://dx.doi.org/10.3390/cells10092324.
Pełny tekst źródłaCitro, Antonio, Elisa Cantarelli, Paola Maffi, Rita Nano, Raffaella Melzi, Alessia Mercalli, Erica Dugnani i in. "CXCR1/2 inhibition enhances pancreatic islet survival after transplantation". Journal of Clinical Investigation 122, nr 10 (1.10.2012): 3647–51. http://dx.doi.org/10.1172/jci63089.
Pełny tekst źródłaLima, Leonardo R., Heloisa M. Falcão Mendes, Frederico M. Soriani, Geraldo Eleno S. Alves, Danielle G. de Souza, Mauro M. Teixeira i Rafael R. Faleiros. "Reparixin, an antagonist of CXCR1/2, in experimental laminitis". Journal of Equine Veterinary Science 33, nr 10 (październik 2013): 871–72. http://dx.doi.org/10.1016/j.jevs.2013.08.055.
Pełny tekst źródłaLu, Min, Lijuan Xia, Mohamed E. Salama i Ronald Hoffman. "Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment". Blood 132, Supplement 1 (29.11.2018): 3057. http://dx.doi.org/10.1182/blood-2018-99-117062.
Pełny tekst źródłaArmstrong, Chris, Jonathan Coulter, Pamela Maxwell, Silvia Berlingeri, Joe M. O'Sullivan, Kevin Prise i David J. Waugh. "Sensitivity of PTEN-deficient prostate carcinoma cells to ionizing radiation through inhibition of treatment-induced CXCL8 signaling." Journal of Clinical Oncology 31, nr 6_suppl (20.02.2013): 154. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.154.
Pełny tekst źródłaKaur, Manpreet, Ramneek, C. S. Mukhopadhyay i Jaspreet Singh Arora. "PCR-SSCP and Sequencing of CXCR1 (IL8RA) Gene in Indian Water Buffalo". International Journal of Applied Sciences and Biotechnology 4, nr 2 (27.06.2016): 228–32. http://dx.doi.org/10.3126/ijasbt.v4i2.15128.
Pełny tekst źródłaRuffini, P. A., L. Brandolini, R. Russo, A. Cimini i M. Allegretti. "CXCR1/2 inhibition prevents paclitaxel- and oxaliplatin-induced peripheral neuropathy". European Journal of Cancer 69 (grudzień 2016): S115. http://dx.doi.org/10.1016/s0959-8049(16)32943-4.
Pełny tekst źródłaCarreira, E. U., V. Carregaro, M. M. Teixeira, A. Moriconi, A. Aramini, W. A. Verri, S. H. Ferreira, F. Q. Cunha i T. M. Cunha. "Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain". European Journal of Pain 17, nr 5 (7.11.2012): 654–63. http://dx.doi.org/10.1002/j.1532-2149.2012.00240.x.
Pełny tekst źródłaHuang, Yunjia, Jichen Yang, Yong Zhang, Shuhong Kuang, Zongshan Shen i Wei Qin. "Blocking CXCR1/2 attenuates experimental periodontitis by suppressing neutrophils recruitment". International Immunopharmacology 128 (luty 2024): 111465. http://dx.doi.org/10.1016/j.intimp.2023.111465.
Pełny tekst źródłaFlorey, Oliver J., Michael Johns, Olubukola O. Esho, Justin C. Mason i Dorian O. Haskard. "Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between FcγRIIa and CXCR1/2". Blood 109, nr 9 (23.01.2007): 3881–89. http://dx.doi.org/10.1182/blood-2006-08-044669.
Pełny tekst źródła